<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib73">
 <label>73</label>
 <mixed-citation publication-type="other" id="sref73">Zhu F. CanSino Biologicsâ€™ Ad5-nCoV the First COVID-19 Vaccine to Phase II Clinical Trials. TrialSiteNews. : Jiangsu Province Centers for Disease Control and Prevention; [updated April 19th, 2020. Available from: 
  <ext-link ext-link-type="uri" xlink:href="https://www.trialsitenews.com/cansino-biologics-ad5-ncov-the-first-covid-19-vaccine-to-phase-ii-clinical-trials/" id="intref0170" xmlns:xlink="http://www.w3.org/1999/xlink">https://www.trialsitenews.com/cansino-biologics-ad5-ncov-the-first-covid-19-vaccine-to-phase-ii-clinical-trials/</ext-link>.
 </mixed-citation>
</ref>
